Yesthe FDA approved Tirzepatide (Zepbound) to treat moderatesevere OSA in adults with obesity (with lifestyle measures)
Bloating and gas by themselves do not usually change the color of stool, but they may signal that digestion is not happening smoothly
Findings indicate elevated oxidative stress markers (MDA, 4-HNE), impaired antioxidant defenses [CoQ10 (Coenzyme Q10), SOD, catalase], and mitochondrial dysfunction in FM patients
Eat meals slowly, stop at light fullness
Ligament injuries heal more slowly than tendons due to even more limited blood supply and constant mechanical stress during recovery
According to the Wegovy website, patients on the medication during the 68 week trial (1 year and 4 months) lost 15.1% of their body weight, the equivalent to approximately 35 pounds